Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4215933 | Revue des Maladies Respiratoires Actualités | 2012 | 6 Pages |
Abstract
Immunotherapeutic agents may become a new, powerful strategy for the management of NSCLC patients. Further investigations are needed to confirm the optimal treatment schedule.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
C. Leduc,